Company / Operating Income per Share
Arbutus Biopharma Corp Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.20
FY2025
5-year range
-$0.82 / -$0.20
FY2021-FY2025
Trend
+55.3%
vs FY2024
Sector context
#64 of 201
Health Care
What the data says
At $-0.20, Arbutus Biopharma Corp's operating income per share ranks #64 of 201 in the Health Care sector. Operating Income per Share has fluctuated over the past 10 years, ranging from $-8.96 in FY2016 to $-0.20 in FY2025.
Based on SEC 10-K filings.
-0.20 in FY2025.
Improved from $-0.50 to $-0.20 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#64 of 201 in Health CareTop 32% of 201This company -$0.20 Sector average -$28.56
▼
+99.3% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 55.3% year-over-year.
- Ranks #64 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -11.01 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.20 | +55.3% |
| FY2024 | -$0.45 | +9.4% |
| FY2023 | -$0.50 | -9.9% |
| FY2022 | -$0.45 | +44.9% |
| FY2021 | -$0.82 | +63.1% |
| FY2020 | -$2.22 | -280.3% |
| FY2019 | -$0.58 | +71.0% |
| FY2018 | -$2.01 | -0.0% |
| FY2017 | -$2.01 | +77.5% |
| FY2016 | -$8.96 | -370.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026